Common use of Commencement of Trial Clause in Contracts

Commencement of Trial. The Institution undertakes not to commence recruitment of potential Subjects to participate in the Trial unless and until the Investigator (i) is notified by Biogen or its agents in writing that all approvals, authorisations and documentation necessary to conduct the Trial have been obtained; (ii) has signed the Protocol thereby agreeing to perform all responsibilities detailed therein; and (iii) has signed the investigator statement a template of which is attached to the Investigator agreement. The Institution shall not conduct research covered under this Agreement, nor administer the Product (or, where applicable, a placebo) to a Subject unless and until the Subject has confirmed in writing his receipt and review of and agreement to an informed consent form for the Trial, a sample copy of which shall be provided to the Institution by Biogen.

Commencement of Trial. The Institution undertakes and the Investigator undertake not to commence recruitment of potential Subjects to participate in the Trial unless and until the Investigator (i) is notified by Biogen or its agents in writing that all approvals, authorisations and documentation necessary to conduct the Trial have been obtained; (ii) has signed the Protocol thereby agreeing to perform all responsibilities detailed therein; and (iii) has signed the investigator statement a template of which is (attached to the Investigator agreementas Schedule B). The Institution Investigator shall not conduct research covered under this Agreement, nor administer the Product (or, where applicable, a placebo) to a Subject unless and until the Subject has confirmed in writing his receipt and review of and agreement to an informed consent form for the Trial, a sample copy of which shall be provided to the Institution by Biogen.

Commencement of Trial. The Institution undertakes Investigator undertake not to commence recruitment of potential Subjects to participate in the Trial unless and until the Investigator (i) is notified by Biogen Idec or its agents in writing that all approvals, authorisations and documentation necessary to conduct the Trial have been obtained; (ii) has signed the Protocol thereby agreeing to perform all responsibilities detailed therein; and (iii) has signed the investigator statement a template of which is (attached to the Investigator agreementas Schedule B). The Institution Investigator shall not conduct research covered under this Agreement, nor administer the Product (or, where applicable, a placebo) to a Subject unless and until the Subject has confirmed in writing his receipt and review of and agreement to an informed consent form for the Trial, a sample copy of which shall be provided to by the Institution by Biogento, and approved Biogen Idec ke schválení.

Commencement of Trial. The Institution undertakes and the Investigator undertake not to commence recruitment of potential Subjects to participate in the Trial unless and until the Investigator (i) is notified by Biogen or its agents in writing that all approvals, authorisations authorizations and documentation necessary to conduct the Trial have been obtained; (ii) has signed the Protocol thereby agreeing to perform all responsibilities detailed therein; and (iii) has signed the investigator statement a template of which is (attached to the as Schedule B).The Investigator agreement. The Institution shall not conduct research covered under this Agreement, nor administer the Product (or, where applicable, a placebo) to a Subject unless and until the Subject has confirmed in writing his receipt and review of and agreement to an informed consent form for the Trial, a sample copy of which shall be provided to the Institution by Biogen.

Commencement of Trial. The Institution undertakes and the Investigator undertake not to commence recruitment of potential Subjects to participate in the Trial unless and until the Investigator (i) is notified by Biogen or its agents in writing that all approvals, authorisations and documentation necessary to conduct the Trial have been obtained; (ii) has signed the Protocol thereby agreeing to perform all responsibilities detailed therein; and (iii) has signed the investigator statement a template of which is (attached to the Investigator agreementas Schedule B). The Institution Investigator shall not conduct research covered under this Agreement, nor administer the Product (or, where applicable, a placebo) to a Subject unless and until the Subject has confirmed in writing his receipt and review of and agreement to an informed consent form for the jehož vzor poskytne Zdravotnickému zařízení společnost Biogen. Trial, a sample copy of which shall be provided to the Institution by Biogen.

Commencement of Trial. The Institution undertakes and the Investigator undertake not to commence recruitment of potential Subjects to participate in the Trial unless and until the Investigator (i) is notified by Biogen or its agents in writing that all approvals, authorisations and documentation necessary to conduct the Trial have been obtained; (ii) has signed the Protocol thereby agreeing to perform all responsibilities detailed therein; and (iii) has signed the investigator statement a template of which is (attached to the as Schedule B).The Investigator agreement. The Institution shall not conduct research covered under this Agreement, nor administer the Product (or, where applicable, a placebo) to a Subject unless and until the Subject has confirmed in writing his receipt and review of and agreement to an informed consent form for the Trial, a sample copy of which shall be provided to the Institution by Biogen.(c)

Commencement of Trial. The Institution undertakes and the Investigator undertake not to commence recruitment of potential Subjects to participate in the Trial unless and until the Investigator (i) is notified by Biogen or its agents in writing that all approvals, authorisations and documentation necessary to conduct the Trial have been obtained; (ii) has signed the Protocol thereby agreeing to perform all responsibilities detailed therein; and (iii) has signed the investigator statement a template of which is (attached to the Investigator agreementas Schedule B). The Institution Investigator shall not conduct research covered under this Agreement, nor administer the Product (or, where applicable, a placebo) to a Subject unless and until the Subject has confirmed in writing his receipt and review of and agreement to an informed consent form for the Trial, a sample copy of which shall be jehož vzor Zdravotnické zařízení obdrží od společnosti Biogen. provided to the Institution by Biogen.

Commencement of Trial. The Institution undertakes and the Investigator undertake not to commence recruitment of potential Subjects to participate in the Trial unless and until the Investigator (i) is notified by Biogen or its agents in writing that all approvals, authorisations and documentation necessary to conduct the Trial have been obtained; (ii) has signed the Protocol thereby agreeing to perform all responsibilities detailed therein; and (iii) has signed the investigator statement a template of which is (attached to the as Schedule B).The Investigator agreement. The Institution shall not conduct research covered under this Agreement, nor administer the Product (or, where applicable, a placebo) to a Subject unless and until the Subject has confirmed in writing his receipt and review of and agreement to an informed consent form for the Trial, a sample copy of which shall be provided to the Institution by Biogen.(c)